Trial Site Detail

 

Drug:
Imatinib + Regorafenib
Trial:
A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST) (ALT GIST)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Helsinki University Central Hospital

     
Helsinki , FIN-00029
Finland

 

Principal Investigator:
Heikki Joensuu, MD
Contact:
mia Viskari +358-9-4711 mia.viskari@hus.fi
Activation Status of this Site:
Active
Notes about this Site:
Helsinki University Central Hospital Website:
http://www.hus.fi/default.asp?path=59

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.